Search research articles
Contact Us
Filters
Showing results (71-80 of 143) with videos related to
Page
of 15
Sort By:
The Journal of Investigative Dermatology
|
March 10, 2019
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients with Moderate-to-Severe Plaque Psoriasis
Yaowei Zhu, Joseph C Marini, Michael Song, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 18, 2018
A comprehensive evaluation of exposure-response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasis
Chuanpu Hu, Zhenling Yao, Yang Chen, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 18, 2017
Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease
Chuanpu Hu, Omoniyi J Adedokun, Yang Chen, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 2, 2018
Joint longitudinal model development: application to exposure-response modeling of ACR and DAS scores in rheumatoid arthritis patients treated with sirukumab
Chuanpu Hu, Yan Xu, Yanli Zhuang, et al.
Journal of Clinical Pharmacology
|
March 24, 2007
Molecular, biologic, and pharmacokinetic properties of monoclonal antibodies: impact of these parameters on early clinical development
Mary Ann Mascelli, Honghui Zhou, Raymond Sweet, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 2020
Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis
Wangda Zhou, Chuanpu Hu, Yaowei Zhu, et al.
Journal of Clinical Pharmacology
|
April 15, 2023
Model-Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti-Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn Disease
Jie Zhou, Yan Xu, Yang Chen, et al.
Clinical Biochemistry
|
September 15, 2025
Reliable LC-MS/MS method development and validation for the determination of methylmalonic acid, methylcitric acid, malonic acid, ethylmalonic acid, and total homocysteine in dried blood spots
Chunyan Zhang, Nan Bai, Yanling Yang, et al.
BMC Pediatrics
|
June 3, 2026
Quality and consistency of genetic newborn screening reports in China: insights from a multi-laboratory analysis using simulated samples
Jiaming Wu, Penghui Feng, Jinming Zhang, et al.
Clinical and Translational Science
|
October 7, 2022
Population-based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma
Liviawati S Wu, Yaming Su, Claire Li, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 143) with videos related to
Sort By:
Page
of 15
The Journal of Investigative Dermatology
|
March 10, 2019
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients with Moderate-to-Severe Plaque Psoriasis
Yaowei Zhu, Joseph C Marini, Michael Song, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 18, 2018
A comprehensive evaluation of exposure-response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasis
Chuanpu Hu, Zhenling Yao, Yang Chen, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 18, 2017
Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease
Chuanpu Hu, Omoniyi J Adedokun, Yang Chen, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 2, 2018
Joint longitudinal model development: application to exposure-response modeling of ACR and DAS scores in rheumatoid arthritis patients treated with sirukumab
Chuanpu Hu, Yan Xu, Yanli Zhuang, et al.
Journal of Clinical Pharmacology
|
March 24, 2007
Molecular, biologic, and pharmacokinetic properties of monoclonal antibodies: impact of these parameters on early clinical development
Mary Ann Mascelli, Honghui Zhou, Raymond Sweet, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 2020
Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis
Wangda Zhou, Chuanpu Hu, Yaowei Zhu, et al.
Journal of Clinical Pharmacology
|
April 15, 2023
Model-Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti-Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn Disease
Jie Zhou, Yan Xu, Yang Chen, et al.
Clinical Biochemistry
|
September 15, 2025
Reliable LC-MS/MS method development and validation for the determination of methylmalonic acid, methylcitric acid, malonic acid, ethylmalonic acid, and total homocysteine in dried blood spots
Chunyan Zhang, Nan Bai, Yanling Yang, et al.
BMC Pediatrics
|
June 3, 2026
Quality and consistency of genetic newborn screening reports in China: insights from a multi-laboratory analysis using simulated samples
Jiaming Wu, Penghui Feng, Jinming Zhang, et al.
Clinical and Translational Science
|
October 7, 2022
Population-based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma
Liviawati S Wu, Yaming Su, Claire Li, et al.
Page
of 15